ziprasidone has been researched along with Disruptive, Impulse Control, and Conduct Disorders in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Keck, PE; Strawn, JR | 1 |
| Alvarez, E; Pascual, JC; Pérez, V; Pérez-Egea, R; Puigdemont, D; Soler, J; Tiana, T | 1 |
1 trial(s) available for ziprasidone and Disruptive, Impulse Control, and Conduct Disorders
| Article | Year |
|---|---|
Ziprasidone in the treatment of borderline personality disorder: a double-blind, placebo-controlled, randomized study.
Topics: Adolescent; Adult; Antipsychotic Agents; Bipolar Disorder; Borderline Personality Disorder; Comorbidity; Depressive Disorder, Major; Disruptive, Impulse Control, and Conduct Disorders; Double-Blind Method; Humans; Middle Aged; Neurocognitive Disorders; Piperazines; Psychoses, Substance-Induced; Schizophrenia; Substance-Related Disorders; Surveys and Questionnaires; Thiazoles | 2008 |
1 other study(ies) available for ziprasidone and Disruptive, Impulse Control, and Conduct Disorders
| Article | Year |
|---|---|
Early bicarbonate loading and dantroline for ziprasidone/haloperidol-induced neuroleptic malignant syndrome.
Topics: Adolescent; Antipsychotic Agents; Autistic Disorder; Combined Modality Therapy; Dantrolene; Disruptive, Impulse Control, and Conduct Disorders; Drug Administration Schedule; Fluid Therapy; Haloperidol; Humans; Male; Muscle Relaxants, Central; Neuroleptic Malignant Syndrome; Piperazines; Self-Injurious Behavior; Sodium Bicarbonate; Thiazoles | 2006 |